Skip to main content
Erschienen in: World Journal of Urology 3/2015

01.03.2015 | Original Article

Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series

verfasst von: Matthias May, Atiqullah Aziz, Sabine Brookman-May, Florian Roghmann, Joachim Noldus, Michael Rink, Felix Chun, Margit Fisch, Vladimir Novotny, Manfred Wirth, Roman Mayr, Armin Pycha, Antonin Brisuda, Björn Volkmer, Regina Stredele, Christopher Dechet, Stefan Vallo, Axel Haferkamp, Marco Schnabel, Stefan Denzinger, Jan Roigas, Christian G. Stief, Christian Gilfrich, Patrick J. Bastian, Jörg B. Engel, Maximilian Burger, Hans-Martin Fritsche

Erschienen in: World Journal of Urology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate for the first time the prognostic significance of female invasive patterns in stage pT4a urothelial carcinoma of the bladder in a large series of women undergoing anterior pelvic exenteration.

Patients and methods

Our series comprised of 92 female patients in total of whom 87 with known invasion patterns were eligible for final analysis. Median follow-up for evaluation of cancer-specific mortality (CSM) was 38 months (interquartile ranges, 21–82 months). The impact on CSM was evaluated using multivariable Cox proportional-hazards regression analysis; predictive accuracy (PA) was assessed by receiver operating characteristic analysis.

Results

Vaginal invasion was noted in 33 patients (37.9 %; group VAG), uterine invasion in 20 patients (23 %; group UT), and infiltration of both vagina and uterus in 34 patients (39.1 %; group VAG + UT). Groups VAG and UT significantly differed from group VAG + UT with regard to the presence of positive soft tissue margins (STM) only. Five-year-cancer-specific survival probabilities in the groups VAG, UT, and VAG + UT were 21, 20, and 21 %, respectively (p = 0.955). On multivariable analysis, only STM status (HR = 2.02, p = 0.023) independently influenced CSM. C-indices of multivariable models for CSM with and without integration of invasive patterns were 0.570 and 0.567, respectively (PA gain 0.3 %, p = 0.526).

Conclusions

Infiltration of the vagina, the uterus or both is associated with poor 5-year survival rates. With regard to CSM, no difference was detectable between patients with different invasion patterns, thus justifying further collectively including these invasive patterns as stage pT4a.
Literatur
1.
Zurück zum Zitat Witjes JA, Compérat E, Cowan NC et al (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792CrossRefPubMed Witjes JA, Compérat E, Cowan NC et al (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792CrossRefPubMed
2.
Zurück zum Zitat Greene FL, Gospodarowicz M, Wittekend C et al (2009) American joint committee on cancer (AJCC) staging manual, 7th edn. Springer, Philadelphia Greene FL, Gospodarowicz M, Wittekend C et al (2009) American joint committee on cancer (AJCC) staging manual, 7th edn. Springer, Philadelphia
3.
Zurück zum Zitat Novara G, Svatek RS, Karakiewicz PI et al (2010) Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 183:2165–2170CrossRefPubMed Novara G, Svatek RS, Karakiewicz PI et al (2010) Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 183:2165–2170CrossRefPubMed
4.
Zurück zum Zitat Tilki D, Svatek RS, Karakiewicz PI et al (2010) Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183:87–93CrossRefPubMed Tilki D, Svatek RS, Karakiewicz PI et al (2010) Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183:87–93CrossRefPubMed
5.
Zurück zum Zitat Liberman D, Alasker A, Sun M et al (2011) Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int 107:905–911CrossRefPubMed Liberman D, Alasker A, Sun M et al (2011) Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int 107:905–911CrossRefPubMed
6.
Zurück zum Zitat Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346CrossRefPubMed Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346CrossRefPubMed
7.
Zurück zum Zitat Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387CrossRefPubMed Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387CrossRefPubMed
8.
Zurück zum Zitat Ali-El-Dein B, Abdel-Latif M, Mosbah A et al (2004) Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely? J Urol 172:885–887CrossRefPubMed Ali-El-Dein B, Abdel-Latif M, Mosbah A et al (2004) Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely? J Urol 172:885–887CrossRefPubMed
9.
Zurück zum Zitat Salem H, El-Mazny A (2011) A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer. Int J Gynaecol Obstet 115:188–190CrossRefPubMed Salem H, El-Mazny A (2011) A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer. Int J Gynaecol Obstet 115:188–190CrossRefPubMed
10.
Zurück zum Zitat Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S (2012) Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer. J Urol 188(6):2134–2138CrossRefPubMed Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S (2012) Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer. J Urol 188(6):2134–2138CrossRefPubMed
11.
Zurück zum Zitat May M, Bastian PJ, Brookman-May S et al (2013) Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 31(7):1141–1147CrossRefPubMed May M, Bastian PJ, Brookman-May S et al (2013) Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 31(7):1141–1147CrossRefPubMed
12.
Zurück zum Zitat Zehnder P, Studer UE, Skinner EC et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186:1261–1268CrossRefPubMed Zehnder P, Studer UE, Skinner EC et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186:1261–1268CrossRefPubMed
13.
Zurück zum Zitat Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a Feasibility Questionnaire. Eur Urol 61(5):1070–1071CrossRefPubMed Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a Feasibility Questionnaire. Eur Urol 61(5):1070–1071CrossRefPubMed
14.
Zurück zum Zitat deVere White RW, Katz MH, Steinberg GD (2009) The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. J Urol 181:1994–1997CrossRefPubMed deVere White RW, Katz MH, Steinberg GD (2009) The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. J Urol 181:1994–1997CrossRefPubMed
Metadaten
Titel
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series
verfasst von
Matthias May
Atiqullah Aziz
Sabine Brookman-May
Florian Roghmann
Joachim Noldus
Michael Rink
Felix Chun
Margit Fisch
Vladimir Novotny
Manfred Wirth
Roman Mayr
Armin Pycha
Antonin Brisuda
Björn Volkmer
Regina Stredele
Christopher Dechet
Stefan Vallo
Axel Haferkamp
Marco Schnabel
Stefan Denzinger
Jan Roigas
Christian G. Stief
Christian Gilfrich
Patrick J. Bastian
Jörg B. Engel
Maximilian Burger
Hans-Martin Fritsche
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 3/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-014-1308-3

Weitere Artikel der Ausgabe 3/2015

World Journal of Urology 3/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.